Clinical Trial Update: Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia [Phase 3]

View source ↗

Summary

This document reports a Phase 3 trial update of bexarotene as an add-on to antipsychotic treatment for chronic schizophrenia, with the trial status noted as com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Bexarotene (Bexarotene)

Snippet

Sponsor: Beersheva Mental Health Center | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED